Search Results

You are looking at 111 - 120 of 818 items for :

  • "screening" x
Clear All
Full access

L. Stewart Massad

test used to improve diagnostic specificity after abnormal screening cytology. However, colposcopy is relatively invasive and costly and can be painful, and recent research has shown that the sensitivity of colposcopy is limited. 10 , 11 Other tests

Full access

J. Thomas Cox

MH . Advances in cervical screening technology . Mod Pathol 2000 ; 13 : 275 – 284 . 18 Hutchinson ML Isenstein LM Goodman A . Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor . Am J Clin

Full access

Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Daniel A. Barocas, Erik P. Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet III, Mark H. Kawachi, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. Morgan, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenke, Andrew J. Vickers, Robert Wake, Dorothy A. Shead and Deborah Freedman-Cass

Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the

Full access

Jeremy Matloff, Aimee Lucas, Alexandros D. Polydorides and Steven H. Itzkowitz

least 2 first- or second-degree relatives with Lynch-associated tumor, regardless of age. 4 The strategies for identifying those with LS continue to evolve as appropriate cancer screening and surveillance programs are initiated for at-risk individuals

Full access

Alice T. Shaw, Benjamin Solomon and Mari Mino Kenudson

. How current methods for detecting ALK could impact screening algorithms for NSCLC patients is also discussed. ALK FISH: The Current Gold Standard The break apart FISH assay for detecting ALK rearrangements has served as the standard test for

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian and Deborah Freedman-Cass

shooting. Neuropathic pain often occurs as a side effect of chemotherapy or radiation therapy or is caused by surgical injury to the nerves. Screening for and Assessment of Pain All cancer survivors should be screened for pain at regular intervals

Full access

Michelle B. Riba, Kristine A. Donovan, Barbara Andersen, IIana Braun, William S. Breitbart, Benjamin W. Brewer, Luke O. Buchmann, Matthew M. Clark, Molly Collins, Cheyenne Corbett, Stewart Fleishman, Sofia Garcia, Donna B. Greenberg, Rev. George F. Handzo, Laura Hoofring, Chao-Hui Huang, Robin Lally, Sara Martin, Lisa McGuffey, William Mitchell, Laura J. Morrison, Megan Pailler, Oxana Palesh, Francine Parnes, Janice P. Pazar, Laurel Ralston, Jaroslava Salman, Moreen M. Shannon-Dudley, Alan D. Valentine, Nicole R. McMillian and Susan D. Darlow

life and may even negatively affect survival. 25 – 28 Furthermore, survivors with untreated distress have poorer compliance with surveillance screenings and are less likely to exercise and quit smoking. 29 Early evaluation and screening for distress

Full access

Rita A. Mukhtar, Jasmine M. Wong and Laura J. Esserman

also reduces morbidity for women who potentially derive little or no benefit from receiving treatments designed for other tumor types. 10 Although tailored treatment has improved outcomes in breast cancer, 10 the implementation of screening programs

Full access

Kaylene Ready and Banu Arun

, proven screening and risk reduction modalities are available. For example, a woman carrying a BRCA1 or BRCA2 mutation can be offered the following risk management options: semiannual breast cancer screening using both mammogram and breast MRI 3

Full access

't treat it, we don't look for it,’” she said. This means that cancer prevention efforts can be largely futile. An individual may be persuaded to undergo a mammogram or colonoscopy, but they often cannot find a location that provides those screenings. Dr